Loading chart…
PRE-MARKET
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products. The company exports its products to Latin American, South East Asian and North African countries Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Albert David Limited (ALBERTDAVD) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ALBERTDAVD share price is ₹800.90 (+2.86% today), with a market capitalisation of ₹5B and a price-to-earnings (P/E) ratio of 20.7. MarketRipple tracks the ALBERTDAVD investment thesis, the ripple-chain impact of market events on Albert David Limited, and the Healthcare sector outlook.
Open
₹808.90
High
₹817.35
Low
₹766.05
Prev. Close
₹778.60
52W High
₹931.85
52W Low
₹579.90
Day range
₹766.05–₹817.35
52-week range
₹579.90–₹931.85
Volume
2K
P/E
20.7
ROE
-0.4%
D/E
0.08
Margin
6.2%
Albert David Limited (NSE: ALBERTDAVD) is currently trading at ₹800.90 (+2.86%).
Albert David Limited's market capitalization is ₹5B.
Albert David Limited's price-to-earnings (P/E) ratio is 20.7.
Albert David Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).